Haemonetics Corporation
NYSE: HAE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Christopher A. Simon
- Employees
- 3,657
- Headquarters
- Boston, United States
- IPO year
- 1991
- Market cap
- $3.3B
- Website
- https://www.haemonetics.com
Loading HAE…
Loading profile data…Frequently asked questions about HAE
What does Haemonetics Corporation (HAE) do?
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessar...
Where does HAE trade?
Haemonetics Corporation (HAE) trades on the New York Stock Exchange.
What sector is HAE in?
Haemonetics Corporation (HAE) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Haemonetics Corporation?
Christopher A. Simon is the chief executive officer of Haemonetics Corporation (HAE).
Where is Haemonetics Corporation headquartered?
Haemonetics Corporation is headquartered in United States.
Does HAE pay a dividend?
Haemonetics Corporation (HAE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HAE go public?
Haemonetics Corporation (HAE) completed its initial public offering in 1991.